Fatty liver infiltration in patients with COPD. An ECLIPSE cohort study

Mickael Martin (Quebec, Canada), Mickael Martin, Natalie Almeras, Jean-Pierre Després, Harvey O Coxson, George R. Washko, Isabelle Vivodtzev, Emiel F.M. Wouters, Erica Rutten, Michelle Williams, John Murchison, William MacNee, Don D. Sin, François Maltais

Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments
Session: Imaging of COPD and airways: structural and functional assessments
Session type: Thematic Poster
Number: 742
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mickael Martin (Quebec, Canada), Mickael Martin, Natalie Almeras, Jean-Pierre Després, Harvey O Coxson, George R. Washko, Isabelle Vivodtzev, Emiel F.M. Wouters, Erica Rutten, Michelle Williams, John Murchison, William MacNee, Don D. Sin, François Maltais. Fatty liver infiltration in patients with COPD. An ECLIPSE cohort study. Eur Respir J 2016; 48: Suppl. 60, 742

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of asthma/COPD overlap within the ECLIPSE study
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015


Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016


The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort
Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation
Year: 2013

Estimation of a disease progression model for COPD using data from the ECLIPSE study
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013

Cardiovascular status of patients with a severe form of COPD
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015


Comorbidities in Swedish COPD and non-COPD patients: ARCTIC study
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016

Lung function and treatment patterns of symptomatic patients with moderate COPD in the CRYSTAL study
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


Comorbidities in patients with COPD and their impact on COPD course
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

Measurement properties of exacerbations of chronic pulmonary disease tool (EXACT) in a clinical trial of patients with moderate to severe COPD
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013


Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014


Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016

Parametric response mapping of COPD phenotypes: A COPDGene study
Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment
Year: 2015


Comorbidities, gender-differences and COPD severity: The French Palomb cohort
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015


COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014

Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016


COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study
Source: International Congress 2014 – Markers
Year: 2014

Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015



Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)
Source: Eur Respir J 2008; 31: 869-873
Year: 2008



Renal impairment a neglected comorbidity in patients with COPD
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016


Top-10 comorbidities of symptomatic patients with moderate COPD in the clinical setting of the CRYSTAL study
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016